Citation: | Katarzyna Woźniczka, Paweł Konieczyński, Alina Plenis, Tomasz Bączek, Anna Roszkowska. SPME as a green sample-preparation technique for the monitoring of phytocannabinoids and endocannabinoids in complex matrices[J]. Journal of Pharmaceutical Analysis, 2023, 13(10): 1117-1134. doi: 10.1016/j.jpha.2023.06.014 |
E.F. Coccaro, M.N. Hill, L. Robinson, et al., Circulating endocannabinoids and affect regulation in human subjects, Psychoneuroendocrinology 92 (2018) 66-71.
|
M.R. Jacobson, J.J. Watts, I. Boileau, et al., A systematic review of phytocannabinoid exposure on the endocannabinoid system: implications for psychosis, Eur. Neuropsychopharmacol. 29 (2019) 330-348.
|
W.A. Devane, L. Hanus, A. Breuer, et al., Isolation and structure of a brain constituent that binds to the cannabinoid receptor, Science 258 (1992) 1946-1949.
|
R. Mechoulam, S. Ben-Shabat, L. Hanus, et al., Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors, Biochem. Pharmacol. 50 (1995) 83-90.
|
M. Maccarrone, Phytocannabinoids and endocannabinoids: different in nature, Rend. Lincei Sci. Fisiche E Nat. 31 (2020) 931-938.
|
M.M. Almeida, C.P. Dias-Rocha, C. Calvino, et al., Lipid endocannabinoids in energy metabolism, stress and developmental programming, Mol. Cell. Endocrinol. 542 (2022), 111522.
|
M. Maccarrone, S. Rossi, M. Bari, et al., Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum, Nat. Neurosci. 11 (2008) 152-159.
|
C. Silvestri, V. Di Marzo, The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders, Cell Metab. 17 (2013) 475-490.
|
C. Marchioni, I.D. de Souza, V.R.A. Junior, et al., Recent advances in LC-MS/MS methods to determine endocannabinoids in biological samples: application in neurodegenerative diseases, Anal. Chim. Acta 1044 (2018) 12-28.
|
I. Smaga, J. Jastrzebska, M. Zaniewska, et al., Changes in the brain endocannabinoid system in rat models of depression, Neurotox. Res. 31 (2017) 421-435.
|
H. Lu, K. Mackie, An introduction to the endogenous cannabinoid system, Biol. Psychiatry 79 (2016) 516-525.
|
S.M. Nugent, B.J. Morasco, M.E. O'Neil, et al., The effects of Cannabis among adults with chronic pain and an overview of general harms, Ann. Intern. Med. 167 (2017), 319.
|
L. Landa, J. Jurica, J. Sliva, et al., Medical cannabis in the treatment of cancer pain and spastic conditions and options of drug delivery in clinical practice, Biomed. Pap. 162 (2018) 18-25.
|
R. de Carvalho Reis, K.J. Almeida, L. da Silva Lopes, et al., Efficacy and adverse event profile of cannabidiol and medicinal cannabis for treatment-resistant epilepsy: systematic review and meta-analysis, Epilepsy Behav. 102 (2020), 106635.
|
B. Vinette, J. Cote, A. El-Akhras, et al., Routes of administration, reasons for use, and approved indications of medical cannabis in oncology: a scoping review, BMC Cancer 22 (2022), 319.
|
K. Lim, Y.M. See, J. Lee, A systematic review of the effectiveness of medical Cannabis for psychiatric, movement and neurodegenerative disorders, Clin. Psychopharmacol. Neurosci. 15 (2017) 301-312.
|
N. Montero-Oleas, I. Arevalo-Rodriguez, S. Nunez-Gonzalez, et al., Therapeutic use of cannabis and cannabinoids: an evidence mapping and appraisal of systematic reviews, BMC Complementary Med. Ther. 20 (2020), 12.
|
P. Berman, K. Futoran, G.M. Lewitus, et al., A new ESI-LC/MS approach for comprehensive metabolic profiling of phytocannabinoids in Cannabis, Sci. Rep. 8 (2018), 14280.
|
P.G. Vasquez-Ocmin, G. Marti, M. Bonhomme, et al., Cannabinoids vs. whole metabolome: relevance of cannabinomics in analyzing Cannabis varieties, Anal. Chim. Acta 1184 (2021), 339020.
|
P. Berman, L. Sulimani, A. Gelfand, et al., Cannabinoidomics - an analytical approach to understand the effect of medical Cannabis treatment on the endocannabinoid metabolome, Talanta 219 (2020), 121336.
|
A. Ligresti, L. De Petrocellis, V. Di Marzo, From phytocannabinoids to cannabinoid receptors and endocannabinoids: pleiotropic physiological and pathological roles through complex pharmacology, Physiol. Rev. 96 (2016) 1593-1659.
|
P. Morales, D.P. Hurst, P.H. Reggio, Molecular targets of the phytocannabinoids: A complex picture. Phytocannabinoids. Cham: Springer, 2017: 103-131.
|
C. Citti, F. Russo, S. Sgro, et al., Pitfalls in the analysis of phytocannabinoids in cannabis inflorescence, Anal. Bioanal. Chem. 412 (2020) 4009-4022.
|
C. Citti, D. Braghiroli, M.A. Vandelli, et al., Pharmaceutical and biomedical analysis of cannabinoids: a critical review, J. Pharm. Biomed. Anal. 147 (2018) 565-579.
|
E. Karschner, M. Swortwood, M. Huestis, Identifying and quantifying cannabinoids in biological matrices in the medical and legal Cannabis era, Clin. Chem. 66 (2020) 888-914.
|
D. Kratz, A. Sens, S.M.G. Schafer, et al., Pre-analytical challenges for the quantification of endocannabinoids in human serum, J. Chromatogr. B 1190 (2022), 123102.
|
V.R. Acquaro Jr, G.A. Gomez-Rios, M. Tascon, et al., Analysis of endocannabinoids in plasma samples by biocompatible solid-phase microextraction devices coupled to mass spectrometry, Anal. Chim. Acta 1091 (2019) 135-145.
|
L. Chu, N. Li, J. Deng, et al., LC-APCI+-MS/MS method for the analysis of ten hormones and two endocannabinoids in plasma and hair from the mice with different gut microbiota, J. Pharm. Biomed. Anal. 185 (2020), 113223.
|
Y. Gong, X. Li, L. Kang, et al., Simultaneous determination of endocannabinoids in murine plasma and brain substructures by surrogate-based LC-MS/MS: application in tumor-bearing mice, J. Pharm. Biomed. Anal. 111 (2015) 57-63.
|
L.J. Ney, K.L. Felmingham, R. Bruno, et al., Simultaneous quantification of endocannabinoids, oleoylethanolamide and steroid hormones in human plasma and saliva, J. Chromatogr. B 1152 (2020), 122252.
|
M. Yu, A. Roszkowska, J. Pawliszyn, In vivo solid-phase microextraction and applications in environmental sciences, ACS Environ. Au 2 (2022) 30-41.
|
A. Roszkowska, N. Miekus, T. Baczek, Application of solid-phase microextraction in current biomedical research, J. Sep. Sci. 42 (2019) 285-302.
|
L. Anzillotti, E. Castrignano, S.S. Rossi, et al., Cannabinoids determination in oral fluid by SPME-GC/MS and UHPLC-MS/MS and its application on suspected drivers, Sci. Justice 54 (2014) 421-426.
|
L. Anzillotti, F. Marezza, L. Calo, et al., Determination of synthetic and natural cannabinoids in oral fluid by solid-phase microextraction coupled to gas chromatography/mass spectrometry: a pilot study, Talanta 201 (2019) 335-341.
|
S. Gentili, C. Mortali, L. Mastrobattista, et al., Determination of different recreational drugs in sweat by headspace solid-phase microextraction gas chromatography mass spectrometry (HS-SPME GC/MS): application to drugged drivers, J. Pharm. Biomed. Anal. 129 (2016) 282-287.
|
E. Boyaci, E. Gionfriddo, A. Roszkowska, et al., Advances in solid phase microextraction (SPME) for metabolomics. Advanced Mass Spectrometry-based Analytical Separation Techniques for Probing the Polar Metabolome. The Royal Society of Chemistry, (2021) 91-124.
|
W. Filipiak, B. Bojko, SPME in clinical, pharmaceutical, and biotechnological research - how far are we from daily practice? Trac Trends Anal. Chem. 115 (2019) 203-213.
|
J. Pawliszyn, Handbook of solid phase microextraction, first ed., Chemical Industry Press, Beijing, 2009.
|
O.J. Portillo-Castillo, R. Castro-Rios, A. Chavez-Montes, et al., Developments of solid-phase microextraction fiber coatings for environmental pharmaceutical and personal care products analysis, Rev. Anal. Chem. 37 (2018), 20170018.
|
C. Marchioni, T.M. Vieira, A.E. Miller Crotti, et al., In-tube solid-phase microextraction with a dummy molecularly imprinted monolithic capillary coupled to ultra-performance liquid chromatography-tandem mass spectrometry to determine cannabinoids in plasma samples, Anal. Chim. Acta 1099 (2020) 145-154.
|
D. Morisue Sartore, J.L. Costa, F.M. Lancas, et al., Packed in-tube SPME-LC-MS/MS for fast and straightforward analysis of cannabinoids and metabolites in human urine, Electrophoresis 43 (2022) 1555-1566.
|
V. Bessonneau, E. Boyaci, M. Maciazek-Jurczyk, et al., In vivo solid phase microextraction sampling of human saliva for non-invasive and on-site monitoring, Anal. Chim. Acta 856 (2015) 35-45.
|
E. Boyaci, K. Gorynski, A. Rodriguez-Lafuente, et al., Introduction of solid-phase microextraction as a high-throughput sample preparation tool in laboratory analysis of prohibited substances, Anal. Chim. Acta 809 (2014) 69-81.
|
N. Reyes-Garces, B. Bojko, J. Pawliszyn, High throughput quantification of prohibited substances in plasma using thin film solid phase microextraction, J. Chromatogr. A 1374 (2014) 40-49.
|
B. Bojko, N. Looby, M. Olkowicz, et al., Solid phase microextraction chemical biopsy tool for monitoring of doxorubicin residue during in vivo lung chemo-perfusion, J. Pharm. Anal. 11 (2021) 37-47.
|
M. Yu, S. Lendor, A. Roszkowska, et al., Metabolic profile of fish muscle tissue changes with sampling method, storage strategy and time, Anal. Chim. Acta 1136 (2020) 42-50.
|
F.M. Musteata, M. Sandoval, J.C. Ruiz-Macedo, et al., Evaluation of in vivo solid phase microextraction for minimally invasive analysis of nonvolatile phytochemicals in Amazonian plants, Anal. Chim. Acta 933 (2016) 124-133.
|
J. Pawliszyn, Evolution of Solid-Phase Microextaction Technology, first ed., Royal Society of Chemistry, 2023.
|
F. Capetti, P. Rubiolo, G. Mastellone, et al., A sustainable approach for the reliable and simultaneous determination of terpenoids and cannabinoids in hemp inflorescences by vacuum assisted headspace solid-phase microextraction, Adv. Sample Prep. 2 (2022), 100014.
|
N. Jornet-Martinez, A. Ortega-Sierra, J. Verdu-Andres, et al., Analysis of contact traces of Cannabis by In-tube solid-phase microextraction coupled to nanoliquid chromatography, Molecules 23 (2018), 2359.
|
A. McDaniel, L. Perry, Q. Liu, et al., Toward the identification of marijuana varieties by headspace chemical forensics, Forensic Chem. 11 (2018) 23-31.
|
M. Aslam, C. Feleder, R.J. Newsom, et al., In vivo monitoring of rat brain endocannabinoids using solid-phase microextraction, Bioanalysis 11 (2019) 1523-1534.
|
I.D. Souza, L.W. Hantao, M.E.C. Queiroz, Polymeric ionic liquid open tubular capillary column for on-line in-tube SPME coupled with UHPLC-MS/MS to determine endocannabinoids in plasma samples, Anal. Chim. Acta 1045 (2019) 108-116.
|
J.C. Cruz, M.A. Rosa, L. Mores, et al., Magnetic restricted-access carbon nanotubes for SPME to determine cannabinoids in plasma samples by UHPLC-MS/MS, Anal. Chim. Acta 1226 (2022), 340160.
|
L.O. Hanus, Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids, Med. Res. Rev. 29 (2009) 213-271.
|
D.A. Reason, M.N.C. Grainger, J.R. Lane, Optimization of the decarboxylation of Cannabis for commercial applications, Ind. Eng. Chem. Res. 61 (2022) 7823-7832.
|
C.A.S. Tanney, R. Backer, A. Geitmann, et al., Cannabis glandular trichomes: a cellular metabolite factory, Front. Plant Sci. 12 (2021), 721986.
|
L.L. Anderson, I.K. Low, S.D. Banister, et al., Pharmacokinetics of phytocannabinoid acids and anticonvulsant effect of cannabidiolic acid in a mouse model of dravet syndrome, J. Nat. Prod. 82 (2019) 3047-3055.
|
V. Desaulniers Brousseau, B.S. Wu, S. MacPherson, et al., Cannabinoids and terpenes: How production of photo-protectants can be manipulated to enhance Cannabis sativa L. phytochemistry, Front. Plant Sci. 12 (2021), 620021.
|
E.B. Russo, The case for the entourage effect and conventional breeding of clinical Cannabis: No “strain,” No gain, Front. Plant Sci. 9 (2019), 1969.
|
A. Sulcova, Pharmacodynamics of cannabinoids, Arch. Pharm. Pharm. Sci. 3 (2019) 11-18.
|
I. Ujvary, L.Hanus, Human metabolites of cannabidiol: a review on their formation, biological activity, and relevance in therapy, Cannabis Cannabinoid Res. 1 (2016) 90-101.
|
R. Deidda, A. Dispas, C. De Bleye, et al., Critical review on recent trends in cannabinoid determination on cannabis herbal samples: from chromatographic to vibrational spectroscopic techniques, Anal. Chim. Acta 1209 (2022), 339184.
|
G. Micalizzi, F. Vento, F. Alibrando, et al., Cannabis Sativa L.: a comprehensive review on the analytical methodologies for cannabinoids and terpenes characterization, J. Chromatogr. A 1637 (2021), 461864.
|
W.H. Abd-Elsalam, M.A. Alsherbiny, J.Y. Kung, et al., LC-MS/MS quantitation of phytocannabinoids and their metabolites in biological matrices, Talanta 204 (2019) 846-867.
|
F. Institute, for D. and M. (BfArM), Cannabis flos Monograph, Deutsches Arzneibuch, Bonn, 2018.
|
F. Institute, for D. and M. (BfArM), Cannabis extractum normatum Monograph, Deutsches Arzneibuch, Bonn, 2020.
|
V. Brighenti, F. Pellati, M. Steinbach, et al., Development of a new extraction technique and HPLC method for the analysis of non-psychoactive cannabinoids in fibre-type Cannabis sativa L. (hemp), J. Pharm. Biomed. Anal. 143 (2017) 228-236.
|
A.J. Ocque, C.E. Hagler, R. DiFrancesco, et al., Development and validation of an assay to measure cannabidiol and Δ9-tetrahydrocannabinol in human EDTA plasma by UHPLC-MS/MS, J. Chromatogr. B 1112 (2019) 56-60.
|
X. Dong, L. Li, Y. Ye, et al., Simultaneous determination of major phytocannabinoids, their main metabolites, and common synthetic cannabinoids in urine samples by LC-MS/MS, J. Chromatogr. B 1033-1034 (2016) 55-64.
|
S. Pichini, S. Malaca, M. Gottardi, et al., UHPLC-MS/MS analysis of cannabidiol metabolites in serum and urine samples. application to an individual treated with medical cannabis, Talanta 223 (2021), 121772.
|
R.C. Kevin, R. Vogel, P. Doohan, et al., A validated method for the simultaneous quantification of cannabidiol, Δ9-tetrahydrocannabinol, and their metabolites in human plasma and application to plasma samples from an oral cannabidiol open-label trial, Drug Test. Anal. 13 (2021) 614-627.
|
A. Scheunemann, K. Elsner, T. Germerott, et al., Simultaneous quantification of 18 different phytocannabinoids in serum using a highly sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method, J. Chromatogr. B 1173 (2021), 122685.
|
J.C. Cruz, L.F.C. Miranda, M.E.C. Queiroz, Pipette tip micro-solid phase extraction (octyl-functionalized hybrid silica monolith) and ultra-high-performance liquid chromatography-tandem mass spectrometry to determine cannabidiol and tetrahydrocannabinol in plasma samples, J. Sep. Sci. 44 (2021) 1621-1632.
|
J.D. Reber, E.L. Karschner, J.Z. Seither, et al., Screening and confirmation methods for the qualitative identification of nine phytocannabinoids in urine by LC-MS/MS, Clin. Biochem. 98 (2021) 54-62.
|
L. Mores, G.R. Borges, R.O. Saga Kitamura, et al., Assessment of a natural extraction phase in disposable pipette extraction coupled with the sub-minute determination of 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid in human urine by fast-GC-FID, Sustain. Chem. Pharm. 20 (2021), 100390.
|
R. Jain, R. Singh, Microextraction techniques for analysis of cannabinoids, Trac Trends Anal. Chem. 80 (2016) 156-166.
|
M. Sergi, C. Montesano, S. Odoardi, et al., Micro extraction by packed sorbent coupled to liquid chromatography tandem mass spectrometry for the rapid and sensitive determination of cannabinoids in oral fluids, J. Chromatogr. A 1301 (2013) 139-146.
|
L.M. Rosendo, T. Rosado, P. Oliveira, et al., The determination of cannabinoids in urine samples using microextraction by packed sorbent and gas chromatography-mass spectrometry, Molecules 27 (2022), 5503.
|
L. Calvi, D. Pentimalli, S. Panseri, et al., Comprehensive quality evaluation of medical Cannabis sativa L. inflorescence and macerated oils based on HS-SPME coupled to GC-MS and LC-HRMS (q-exactive orbitrap®) approach, J. Pharm. Biomed. Anal. 150 (2018) 208-219.
|
M. Ternelli, V. Brighenti, L. Anceschi, et al., Innovative methods for the preparation of medical Cannabis oils with a high content of both cannabinoids and terpenes, J. Pharm. Biomed. Anal. 186 (2020), 113296.
|
M. Huestis, Human cannabinoid pharmacokinetics, Chem. Biodivers. 4 (2007) 1770-1804.
|
J.C. Cruz, M.A. Rosa, L. Mores, et al., Magnetic restricted-access carbon nanotubes for SPME to determine cannabinoids in plasma samples by UHPLC-MS/MS, Anal. Chim. Acta 1226 (2022), 340160.
|
N. Reyes-Garces, E. Gionfriddo, G.A. Gomez-Rios, et al., Advances in solid phase microextraction and perspective on future directions, Anal. Chem. 90 (2018) 302-360.
|
O.H. Drummer, Drug testing in oral fluid, Clin. Biochem. Rev. 27 (2006) 147-159.
|
T. Franklin, L. Perry, W.C. Shih, et al., Detection of phytocannabinoids from buccal swabs by headspace solid phase microextraction-gas chromatography/mass spectrometry, Anal. Methods 10 (2018) 942-946.
|
B. Moosmann, N. Roth, M. Hastedt, et al., Cannabinoid findings in children hair - what do they really tell us? an assessment in the light of three different analytical methods with focus on interpretation of Δ9-tetrahydrocannabinolic acid A concentrations, Drug Test. Anal. 7 (2015) 349-357.
|
E.M. Wymore, C. Palmer, G.S. Wang, et al., Persistence of Δ-9-tetrahydrocannabinol in human breast milk, JAMA Pediatr. 175 (2021), 632.
|
G. de Oliveira Silveira, S. Loddi, C.D.R. de Oliveira, et al., Headspace solid-phase microextraction and gas chromatography-mass spectrometry for determination of cannabinoids in human breast milk, Forensic Toxicol. 35 (2017) 125-132.
|
R. Cooray, V. Gupta, C. Suphioglu, Current aspects of the endocannabinoid system and targeted THC and CBD phytocannabinoids as potential therapeutics for Parkinson's and Alzheimer's diseases: a review, Mol. Neurobiol. 57 (2020) 4878-4890.
|
K.R. Kozak, B.C. Crews, J.D. Morrow, et al., Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides, J. Biol. Chem. 277 (2002) 44877-44885.
|
P. Urquhart, A. Nicolaou, D.F. Woodward, Endocannabinoids and their oxygenation by cyclo-oxygenases, lipoxygenases and other oxygenases, Biochim. Biophys. Acta BBA Mol. Cell Biol. Lipids 1851 (2015) 366-376.
|
D. Luque-Cordoba, M. Calderon-Santiago, M.D. Luque de Castro, et al., Study of sample preparation for determination of endocannabinoids and analogous compounds in human serum by LC-MS/MS in MRM mode, Talanta 185 (2018) 602-610.
|
T.A. de Roon-Cassini, C.L. Bergner, S.A. Chesney, et al., Circulating endocannabinoids and genetic polymorphisms as predictors of posttraumatic stress disorder symptom severity: Heterogeneity in a community-based cohort, Transl. Psychiatry 12 (2022), 48.
|
V. Kantae, S. Ogino, M. Noga, et al., Quantitative profiling of endocannabinoids and related N-acylethanolamines in human CSF using nano LC-MS/MS, J. Lipid Res. 58 (2017) 615-624.
|
M. Bobrich, R. Schwarz, R. Ramer, et al., A simple LC-MS/MS method for the simultaneous quantification of endocannabinoids in biological samples, J. Chromatogr. B 1161 (2020), 122371.
|
C.D. Voegel, M.R. Baumgartner, T. Kraemer, et al., Simultaneous quantification of steroid hormones and endocannabinoids (ECs) in human hair using an automated supported liquid extraction (SLE) and LC-MS/MS - insights into EC baseline values and correlation to steroid concentrations, Talanta 222 (2021), 121499.
|
A. Behnke, A.M. Gumpp, A. Krumbholz, et al., Hair-based biomarkers in women with major depressive disorder: glucocorticoids, endocannabinoids, N-acylethanolamines, and testosterone, Compr. Psychoneuroendocrinol. 7 (2021), 100068.
|
W. Gao, A. Walther, M. Wekenborg, et al., Determination of endocannabinoids and N-acylethanolamines in human hair with LC-MS/MS and their relation to symptoms of depression, burnout, and anxiety, Talanta 217 (2020), 121006.
|
S. Pati, S. Krishna, J.H. Lee, et al., Effects of high-fat diet and age on the blood lipidome and circulating endocannabinoids of female C57BL/6 mice, Biochim. Biophys. Acta BBA Mol. Cell Biol. Lipds. 1863 (2018) 26-39.
|
D. Kratz, D. Thomas, R. Gurke, Endocannabinoids as potential biomarkers: It‘s all about pre-analytics, J. Mass Spectrom. Adv. Clin. Lab 22 (2021) 56-63.
|
A.M. Dickens, F. Borgan, H. Laurikainen, et al., Links between central CB1-receptor availability and peripheral endocannabinoids in patients with first episode psychosis, NPJ Schizophr. 6 (2020), 21.
|
I.G.C. Oliveira, I.D. de Souza, G.C. do Nascimento, et al., In-tube solid-phase microextraction directly coupled to tandem mass spectrometry for anandamide and 2-arachidonoylglycerol determination in rat brain samples from an animal model of Parkinson's disease, J. Chromatogr. A 1636 (2021), 461766.
|
A. Roszkowska, I. Klejbor, J. Bogusiewicz, et al., Monitoring of age- and gender-related alterations of endocannabinoid levels in selected brain regions with the use of SPME probes, Metabolomics 19 (2023), 40.
|